Source: Basic & Clinical Pharmacology & Toxicology. Unidade: FMRP
Subjects: ADIPONECTINA, INIBIDORES DE ENZIMAS (FARMACOLOGIA), HIPERTENSÃO, LEPTINA, REGRESSÃO LINEAR
ABNT
FONTANA, Vanessa et al. Effects of angiotensin-converting enzyme inhibition on leptin and adiponectin levels in essential hypertension. Basic & Clinical Pharmacology & Toxicology, v. 114, n. 6, p. 472–475, 2014Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12195. Acesso em: 21 out. 2024.APA
Fontana, V., Faria, A. P. C. de, Oliveira-Paula, G. H., Silva, P. S., Biagi, C., Tanus-Santos, J. E., & Moreno, H. (2014). Effects of angiotensin-converting enzyme inhibition on leptin and adiponectin levels in essential hypertension. Basic & Clinical Pharmacology & Toxicology, 114( 6), 472–475. doi:10.1111/bcpt.12195NLM
Fontana V, Faria APC de, Oliveira-Paula GH, Silva PS, Biagi C, Tanus-Santos JE, Moreno H. Effects of angiotensin-converting enzyme inhibition on leptin and adiponectin levels in essential hypertension [Internet]. Basic & Clinical Pharmacology & Toxicology. 2014 ; 114( 6): 472–475.[citado 2024 out. 21 ] Available from: https://doi.org/10.1111/bcpt.12195Vancouver
Fontana V, Faria APC de, Oliveira-Paula GH, Silva PS, Biagi C, Tanus-Santos JE, Moreno H. Effects of angiotensin-converting enzyme inhibition on leptin and adiponectin levels in essential hypertension [Internet]. Basic & Clinical Pharmacology & Toxicology. 2014 ; 114( 6): 472–475.[citado 2024 out. 21 ] Available from: https://doi.org/10.1111/bcpt.12195